RESUMEN
INTRODUCTION: Both cannabis use and depressive symptomology increase in prevalence throughout adolescence. Concurrently, the brain is undergoing neurodevelopment in important limbic regions, such as the amygdala. Prior research indicates the amygdala may also be related to cannabis use and depressive symptoms. We aimed to investigate the effects of adolescent cannabis use on amygdala volumes as well as the interaction of cannabis use and amygdala morphometry on depressive symptoms in youth. METHOD: Two-hundred-twenty-four participants (ages 12-15), balanced by sex assigned at birth, were selected from a sub-sample of the Adolescent Brain Cognitive Development (ABCD) Study based on hair toxicology and self-report measures of cannabis use. Participants positive for cannabinoids in hair and/or self-reported cannabis use were demographically matched to youth with no self-reported or confirmed cannabis use. The guardians of these youth reported depression symptoms on the Child Behavioral Checklist. Linear mixed effect models were run investigating cannabis use group on amygdala volumes bilaterally, controlling for whole brain volume and random effects of scanner type. Additional analyses examined cannabis group status and bilateral amygdala volume on depression symptoms. RESULTS: Cannabis use was not significantly associated with amygdala volume but was associated with increased depressive symptoms (p<0.01). Cannabis group interacted with amygdala volume, such that individuals with smaller volumes had increased depressive symptoms within the cannabis group (p's<0.01-0.02). CONCLUSION: Aberrations in amygdala volume based on cannabis use were not found in early adolescence; however, more depressive symptoms were related to cannabis group. Youth who use cannabis and have smaller amygdala volumes were at increased risk for depressive symptomology, suggesting potential neurovulnerabilities to cannabis use.
Asunto(s)
Amígdala del Cerebelo , Depresión , Imagen por Resonancia Magnética , Humanos , Adolescente , Amígdala del Cerebelo/diagnóstico por imagen , Amígdala del Cerebelo/patología , Masculino , Femenino , Depresión/diagnóstico por imagen , Depresión/inducido químicamente , Niño , Cannabis/efectos adversos , Uso de la Marihuana/efectos adversos , Abuso de Marihuana/patología , Abuso de Marihuana/diagnóstico por imagen , AutoinformeRESUMEN
Co-occurrence of drug misuse with other dysregulated behaviors is common. This study was aimed at exploring the associations between the risk of presenting a clinically relevant condition involving non-substance-related addictive or dysregulated behaviors (as measured by the MultiCAGE CAD-4 screening), and cannabis abuse/dependence (CAST/SDS) scores, and the role of gender therein. Participants were recruited using stratified probabilistic sampling at the University of Granada. Mann-Whitney's U tests were used to compare male and female students in SDS and CAST scores. Associations between gender and MultiCAGE scores were estimated using the γ ordinal correlation index, and tested with χ2. For each MultiCAGE dimension, a Poisson-family mixed-effects model was built with either SDS or CAST as the main input variable, while controlling for nicotine and alcohol dependence, and relevant sociodemographic variables. Incidence rate ratios (IRR) were computed for SDS/CAST effects, and the significance threshold was family-wise Bonferroni-corrected. Gender differences were significant for cannabis dependence/abuse and all MultiCAGE scores for non-substance-related conditions, with males showing higher risk scores for excessive gambling, excessive internet use, excessive video gaming, and hypersexuality, and females presenting higher scores in dysregulated eating and compulsive buying. Cannabis dependence and abuse were significantly associated with a higher risk of problematic video gaming. These associations were mostly driven by males. Importantly, although risk of problematic video gaming was specifically associated with cannabis abuse/dependence, there was only a weak non-significant association between problematic video gaming and alcohol use scores. Risk of alcohol use problems, in turn, was strongly associated with all other non-substance-related problems (problematic gambling, excessive Internet use, dysregulated eating, compulsive buying, and hypersexuality). These differential associations can cast light on the etiological similarities and dissimilarities between problematic substance use and putative addictive behaviors not involving drugs.
Asunto(s)
Conducta Adictiva/epidemiología , Abuso de Marihuana/patología , Trastornos Relacionados con Sustancias/patología , Adulto , Alcoholismo/complicaciones , Alcoholismo/epidemiología , Conducta Adictiva/complicaciones , Trastornos de Alimentación y de la Ingestión de Alimentos/complicaciones , Trastornos de Alimentación y de la Ingestión de Alimentos/epidemiología , Femenino , Juego de Azar/complicaciones , Juego de Azar/epidemiología , Humanos , Masculino , Abuso de Marihuana/complicaciones , Factores de Riesgo , Sexualidad , Estadísticas no Paramétricas , Trastornos Relacionados con Sustancias/complicaciones , Tabaquismo/complicaciones , Tabaquismo/epidemiología , Juegos de Video/estadística & datos numéricos , Adulto JovenRESUMEN
BACKGROUND AND OBJECTIVES: Epidemiological studies show that the use of cannabis is related to the use of other illicit drugs, including stimulants such as cocaine and ecstasy. However, few studies have examined how patterns of cannabis use relate to the use of stimulants. In this research we determined relationships between patterns of cannabis use and recent stimulant use, drawing on data from two large nationally representative surveys. We also explored how frequency of cannabis use relates to stimulant use and whether subjects with a cannabis use disorder (CUD)-defined as cannabis abuse or dependence-are more likely to be recent users of cocaine or ecstasy. MATERIALS AND METHODS: We analysed data from Ireland's 2010/11 and 2014/15 National Drug Prevalence Surveys,which recruited 5,134 and 7,005 individuals respectively, aged 15 years and over, living in private households. We included only those people who reported some past cannabis use. Multivariable logistic regression analysis was used to examine associations between patterns of cannabis use and recent stimulant use. RESULTS: Among survey participants who had used cannabis in the last month, 17.9% reported recent cocaine use, while almost one-quarter (23.6%) reported recent ecstasy use. There was a significant linear relationship between patterns of cannabis use and recent use of cocaine, ecstasy or any stimulant, with last month cannabis users displaying greater odds (OR = 12.03, 95% CI: 8.15-17.78) of having recent stimulant use compared to last year (OR = 4.48, 95% CI: 2.91-6.91) and former (reference) cannabis users. Greater frequency of cannabis use in the last 30 days was also significantly related to the use of stimulants. In addition, results demonstrated an association between CUD and recent use of cocaine or ecstasy (OR = 2.28, 95% CI: 1.55-3.35). CONCLUSIONS: Findings from this study suggest a relationship between patterns and frequency of cannabis use and recent use of stimulants and an association between CUD and stimulant use. As the use of cannabis with stimulants may increase the risk of negative health consequences, education in community and medical settings about polydrug use and its increased risks may be warranted.
Asunto(s)
Cannabis/efectos adversos , Trastornos Relacionados con Cocaína/epidemiología , Abuso de Marihuana/epidemiología , Fumar Marihuana/efectos adversos , Adolescente , Adulto , Estimulantes del Sistema Nervioso Central/efectos adversos , Cocaína/efectos adversos , Trastornos Relacionados con Cocaína/patología , Femenino , Alucinógenos/efectos adversos , Humanos , Irlanda/epidemiología , Masculino , Abuso de Marihuana/patología , Adulto JovenRESUMEN
Cannabis effects are predominantly mediated by pharmacological actions on cannabinoid type 1 (CB1 ) receptors. Prior positron emission tomography (PET) studies in individuals who use cannabis included almost exclusively males. PET studies in females are needed because there are sex differences in cannabis effects, progression to cannabis use disorder (CUD), and withdrawal symptom severity. Females with CUD (N = 10) completed two double-blind cannabis smoking sessions (Session 1: placebo; Session 2: active), and acute cannabis effects were assessed. After Session 2, participants underwent 3 days of monitored cannabis abstinence; mood, craving, and withdrawal symptoms were assessed and a PET scan (radiotracer: [11 C]OMAR) followed. [11 C]OMAR Distribution volume (VT ) from these participants was compared with VT of age/BMI-similar female non-users of cannabis ("healthy controls"; N = 10). VT was also compared between female and male healthy controls (N = 7). Females with CUD displayed significantly lower VT than female healthy controls in specific brain regions (hippocampus, amygdala, cingulate, and insula). Amygdala VT was negatively correlated with mood changes (anger/hostility) during abstinence, but VT was not correlated with other withdrawal symptoms or cannabis effects. Among healthy controls, females had significantly higher VT than males in all brain regions examined. Chronic cannabis use appears to foster downregulation of CB1 receptors in women, as observed previously in men, and there are inherent sex differences in CB1 availability. Future studies should elucidate the time course of CB1 downregulation among females who use cannabis and examine the relation between CB1 availability and cannabis effects among other populations (e.g., infrequent users; medicinal users).
Asunto(s)
Encéfalo/efectos de los fármacos , Abuso de Marihuana/patología , Receptor Cannabinoide CB1/efectos de los fármacos , Síndrome de Abstinencia a Sustancias/patología , Adulto , Afecto/efectos de los fármacos , Factores de Edad , Índice de Masa Corporal , Encéfalo/diagnóstico por imagen , Ansia/efectos de los fármacos , Método Doble Ciego , Femenino , Hipocampo/efectos de los fármacos , Humanos , Masculino , Abuso de Marihuana/diagnóstico por imagen , Gravedad del Paciente , Tomografía de Emisión de Positrones , Radiofármacos/farmacocinética , Autoadministración , Adulto JovenRESUMEN
Sub-Saharan Africa is one of the top three regions with the highest rates of opioid-related premature mortality. Nyaope is the street name for what is believed to be a drug cocktail in South Africa although recent research suggests that it is predominantly heroin. Nyaope powder is most commonly smoked together with cannabis, a drug-use pattern unique to the region. Due to the increasing burden of this drug in low-income communities and the absence of human structural neuroimaging data of combination heroin and cannabis use disorder, we initiated an important cohort study in order to identify neuroanatomical sequelae. Twenty-eight male nyaope users and thirty healthy, matched controls were recruited from drug rehabilitation centers and the community, respectively. T1-weighted MRI images were obtained using a 3 T General Electric Discovery and cortical thickness was examined and compared. Nyaope users displayed extensive grey matter atrophy in the right hemispheric medial orbitofrontal, rostral middle frontal, superior temporal, superior frontal, and supramarginal gyri (two-sided t-test, p < 0.05, corrected for multiple comparisons). Our findings indicate cortical abnormality in nyaope users in regions involved in impulse control, decision making, social- and self-perception, and working memory. Importantly, affected brain regions show large overlap with the pattern of cortical abnormalities shown in heroin use disorder.
Asunto(s)
Corteza Cerebral/patología , Sustancia Gris/patología , Dependencia de Heroína/patología , Drogas Ilícitas/farmacología , Abuso de Marihuana/patología , Adulto , Atrofia/inducido químicamente , Atrofia/diagnóstico por imagen , Cannabis , Estudios de Casos y Controles , Corteza Cerebral/diagnóstico por imagen , Corteza Cerebral/efectos de los fármacos , Estudios de Cohortes , Sustancia Gris/diagnóstico por imagen , Sustancia Gris/efectos de los fármacos , Heroína/farmacología , Dependencia de Heroína/diagnóstico por imagen , Humanos , Imagen por Resonancia Magnética/métodos , Masculino , Abuso de Marihuana/diagnóstico por imagen , Neuroimagen , SudáfricaRESUMEN
Although previous studies have highlighted associations of cannabis use with cognition and brain morphometry, critical questions remain with regard to the association between cannabis use and brain structural and functional connectivity. In a cross-sectional community sample of 205 African Americans (age 18-70) we tested for associations of cannabis use disorder (CUD, n = 57) with multi-domain cognitive measures and structural, diffusion, and resting state brain-imaging phenotypes. Post hoc model evidence was computed with Bayes factors (BF) and posterior probabilities of association (PPA) to account for multiple testing. General cognitive functioning, verbal intelligence, verbal memory, working memory, and motor speed were lower in the CUD group compared with non-users (p < .011; 1.9 < BF < 3,217). CUD was associated with altered functional connectivity in a network comprising the motor-hand region in the superior parietal gyri and the anterior insula (p < .04). These differences were not explained by alcohol, other drug use, or education. No associations with CUD were observed in cortical thickness, cortical surface area, subcortical or cerebellar volumes (0.12 < BF < 1.5), or graph-theoretical metrics of resting state connectivity (PPA < 0.01). In a large sample collected irrespective of cannabis used to minimize recruitment bias, we confirm the literature on poorer cognitive functioning in CUD, and an absence of volumetric brain differences between CUD and non-CUD. We did not find evidence for or against a disruption of structural connectivity, whereas we did find localized resting state functional dysconnectivity in CUD. There was sufficient proof, however, that organization of functional connectivity as determined via graph metrics does not differ between CUD and non-user group.
Asunto(s)
Corteza Cerebral , Disfunción Cognitiva , Abuso de Marihuana , Red Nerviosa , Adulto , Negro o Afroamericano , Anciano , Corteza Cerebral/diagnóstico por imagen , Corteza Cerebral/patología , Corteza Cerebral/fisiopatología , Disfunción Cognitiva/diagnóstico por imagen , Disfunción Cognitiva/etiología , Disfunción Cognitiva/patología , Disfunción Cognitiva/fisiopatología , Conectoma , Estudios Transversales , Femenino , Humanos , Imagen por Resonancia Magnética , Masculino , Abuso de Marihuana/complicaciones , Abuso de Marihuana/diagnóstico por imagen , Abuso de Marihuana/patología , Abuso de Marihuana/fisiopatología , Persona de Mediana Edad , Red Nerviosa/diagnóstico por imagen , Red Nerviosa/patología , Red Nerviosa/fisiopatología , Adulto JovenRESUMEN
BACKGROUND: Little is known regarding the association of cannabis use with brain structure in adolescents with bipolar disorder (BD). This subject is timely, given expanded availability of cannabis contemporaneously with increased social acceptance and diminished societal constraints to access. Therefore, we set out to examine this topic in a sample of adolescents with BD and healthy control (HC) adolescents. METHODS: Participants included 144 adolescents (47 BD with cannabis use [BDCB+; including 13 with cannabis use disorder], 34 BD without cannabis use [BDCB-], 63 HC without cannabis use) ages 13-20 years. FreeSurfer-processed 3T MRI with T1-weighted contrast yielded measures of cortical thickness, surface area (SA), and volume. Region of interest (amygdala, hippocampus, ventrolateral prefrontal cortex, ventromedial prefrontal cortex, and anterior cingulate cortex) analyses and exploratory vertex-wise analysis were undertaken. A general linear model tested for between-group differences, accounting for age, sex, and intracranial volume. RESULTS: Vertex-wise analysis revealed significant group effects in frontal and parietal regions. In post-hoc analyses, BDCB+ exhibited larger volume and SA in parietal regions, and smaller thickness in frontal regions, relative to HC and BDCB-. BDCB- had smaller volume, SA, and thickness in parietal and frontal regions relative to HC. There were no significant region of interest findings after correcting for multiple comparisons. CONCLUSION: This study found that cannabis use is associated with differences in regional brain structure among adolescents with BD. Future prospective studies are necessary to determine the direction of the observed association and to assess for dose effects.
Asunto(s)
Amígdala del Cerebelo/patología , Trastorno Bipolar/patología , Corteza Cerebral/patología , Abuso de Marihuana/patología , Uso de la Marihuana/patología , Adolescente , Adulto , Amígdala del Cerebelo/diagnóstico por imagen , Trastorno Bipolar/diagnóstico por imagen , Corteza Cerebral/diagnóstico por imagen , Femenino , Humanos , Imagen por Resonancia Magnética , Masculino , Abuso de Marihuana/diagnóstico por imagen , Adulto JovenRESUMEN
Cannabis is the illicit drug most commonly used worldwide, and its consumption can both induce psychiatric symptoms in otherwise healthy subjects and unmask a florid psychotic picture in patients with a prior psychotic risk. Previous studies suggest that chronic and long-term cannabis exposure may exert significant negative effects in brain areas enriched with cannabinoid receptors. However, whether brain alterations determined by cannabis dependency will lead to a clinically significant phenotype or to a psychotic outbreak at some point of an abuser's life remains unclear. The aim of this study was to investigate morphological brain differences between chronic cannabis users with cannabis-induced psychosis (CIP) and non-psychotic cannabis users (NPCU) without any psychiatric conditions and correlate brain deficits with selective socio-demographic, clinical and psychosocial variables. 3T magnetic resonance imaging (MRI) scans of 10 CIP patients and 12 NPCU were acquired. The type of drug, the frequency, and the duration, as well socio-demographic, clinical and psychosocial parameters of dependency were measured. CIP patients had extensive grey matter (GM) decreases in right superior frontal gyrus, right precentral, right superior temporal gyrus, insula bilaterally, right precuneus, right medial occipital gyrus, right fusiform gyrus, and left hippocampus in comparison to chronic cannabis users without psychosis. Finally, in CIP patients, the results showed a negative correlation between a domain of the Brief Psychiatric Rating Scale (BPRS), BPRS-Activity, and selective GM volumes. Overall, the results suggest that cannabis-induced psychosis is characterized by selective brain reductions that are not present in NPCU. Therefore, neuroimaging studies may provide a potential ground for identifying putative biomarkers associated with the risk of developing psychosis in cannabis users.
Asunto(s)
Encéfalo/diagnóstico por imagen , Abuso de Marihuana/diagnóstico por imagen , Psicosis Inducidas por Sustancias/diagnóstico por imagen , Adulto , Encéfalo/patología , Femenino , Sustancia Gris/diagnóstico por imagen , Sustancia Gris/patología , Humanos , Imagen por Resonancia Magnética , Masculino , Abuso de Marihuana/epidemiología , Abuso de Marihuana/patología , Neuroimagen , Proyectos Piloto , Psicosis Inducidas por Sustancias/epidemiología , Psicosis Inducidas por Sustancias/patologíaRESUMEN
OBJECTIVES: We aimed to investigate whether severity of cannabis dependence is associated with the neuroanatomy of key brain regions of the stress and reward brain circuits. METHODS: To examine dependence-specific regional brain alterations, we compared the volumes of regions relevant to reward and stress, between high-dependence cannabis users (CD+, n = 25), low-dependence cannabis users (CD-, n = 20) and controls (n = 37). RESULTS: Compared to CD- and/or controls, the CD+ group had lower cerebellar white matter and hippocampal volumes, and deflation of the right hippocampus head and tail. CONCLUSION: These findings provide initial support for neuroadaptations involving stress and reward circuits that are specific to high-dependence cannabis users.
Asunto(s)
Cerebelo/patología , Hipocampo/patología , Abuso de Marihuana/patología , Sustancia Blanca/patología , Adulto , Núcleo Caudado/diagnóstico por imagen , Núcleo Caudado/patología , Cerebelo/diagnóstico por imagen , Femenino , Hipocampo/diagnóstico por imagen , Humanos , Imagen por Resonancia Magnética , Masculino , Abuso de Marihuana/diagnóstico por imagen , Abuso de Marihuana/fisiopatología , Hipófisis/diagnóstico por imagen , Hipófisis/patología , Índice de Severidad de la Enfermedad , Sustancia Blanca/diagnóstico por imagen , Adulto JovenRESUMEN
Cannabis, the most widely used illicit drug worldwide, produces psychoactive effects through its component cannabinoids, which act on the endocannabinoid system. Research on how cannabinoid exposure affects the endocannabinoid system is limited. Substantial evidence indicates cannabis use as a risk factor for psychosis, and the mechanism(s) by which this is occurring is/are currently unknown. Here, we conduct the first review of the effects of exogenous cannabinoids on the endocannabinoid system in humans with and without psychotic disorders. The most well established finding is the down-regulation of cannabinoid CB1 receptors (CB1R) after chronic and recent cannabis exposure, but it remains uncertain whether this effect is present in cannabis users with schizophrenia. We highlight where cannabis exposure affects the endocannabinoid system in a pattern that may mirror what is seen in psychosis, and how further research can push this field forward. In these times of changing cannabis legislation, research highlighting the biological effects of cannabinoids is greatly needed.
Asunto(s)
Cannabinoides/farmacología , Endocannabinoides/metabolismo , Receptor Cannabinoide CB1/metabolismo , Esquizofrenia/metabolismo , Moduladores de Receptores de Cannabinoides/farmacología , Humanos , Abuso de Marihuana/metabolismo , Abuso de Marihuana/patología , PubMed/estadística & datos numéricos , Esquizofrenia/patología , Transducción de Señal/efectos de los fármacos , Transducción de Señal/fisiologíaRESUMEN
Cellular studies indicate that endocannabinoid type-1 retrograde signaling plays a major role in synaptic plasticity. Disruption of these processes by delta-9-tetrahydrocannabinol (THC) could produce alterations either in structural and functional brain connectivity or in their association in cannabis (CB) users. Graph theoretic structural and functional networks were generated with diffusion tensor imaging and resting-state functional imaging in 37 current CB users and 31 healthy non-users. The primary outcome measures were coupling between structural and functional connectivity, global network characteristics, association between the coupling and network properties, and measures of rich-club organization. Structural-functional (SC-FC) coupling was globally preserved showing a positive association in current CB users. However, the users had disrupted associations between SC-FC coupling and network topological characteristics, most perturbed for shorter connections implying region-specific disruption by CB use. Rich-club analysis revealed impaired SC-FC coupling in the hippocampus and caudate of users. This study provides evidence of the abnormal SC-FC association in CB users. The effect was predominant in shorter connections of the brain network, suggesting that the impact of CB use or predispositional factors may be most apparent in local interconnections. Notably, the hippocampus and caudate specifically showed aberrant structural and functional coupling. These structures have high CB1 receptor density and may also be associated with changes in learning and habit formation that occur with chronic cannabis use.
Asunto(s)
Núcleo Caudado , Hipocampo , Abuso de Marihuana , Uso de la Marihuana , Red Nerviosa , Adulto , Núcleo Caudado/diagnóstico por imagen , Núcleo Caudado/patología , Núcleo Caudado/fisiopatología , Conectoma , Imagen de Difusión Tensora , Femenino , Hipocampo/diagnóstico por imagen , Hipocampo/patología , Hipocampo/fisiopatología , Humanos , Masculino , Abuso de Marihuana/diagnóstico por imagen , Abuso de Marihuana/patología , Abuso de Marihuana/fisiopatología , Red Nerviosa/diagnóstico por imagen , Red Nerviosa/patología , Red Nerviosa/fisiopatología , Adulto JovenRESUMEN
Cannabis use is highly prevalent and often considered to be relatively harmless. Nonetheless, a subset of regular cannabis users may develop dependence, experiencing poorer quality of life and greater mental health problems relative to non-dependent users. The neuroanatomy characterizing cannabis use versus dependence is poorly understood. We aimed to delineate the contributing role of cannabis use and dependence on morphology of the hippocampus, one of the most consistently altered brain regions in cannabis users, in a large multi-site dataset aggregated across four research sites. We compared hippocampal volume and vertex-level hippocampal shape differences (1) between 121 non-using controls and 140 cannabis users; (2) between 106 controls, 50 non-dependent users and 70 dependent users; and (3) between a subset of 41 controls, 41 non-dependent users and 41 dependent users, matched on sample characteristics and cannabis use pattern (onset age and dosage). Cannabis users did not differ from controls in hippocampal volume or shape. However, cannabis-dependent users had significantly smaller right and left hippocampi relative to controls and non-dependent users, irrespective of cannabis dosage. Shape analysis indicated localized deflations in the superior-medial body of the hippocampus. Our findings support neuroscientific theories postulating dependence-specific neuroadaptations in cannabis users. Future efforts should uncover the neurobiological risk and liabilities separating dependent and non-dependent use of cannabis.
Asunto(s)
Hipocampo/diagnóstico por imagen , Abuso de Marihuana/diagnóstico por imagen , Uso de la Marihuana/patología , Adolescente , Adulto , Estudios de Casos y Controles , Femenino , Hipocampo/patología , Humanos , Imagen por Resonancia Magnética , Masculino , Abuso de Marihuana/patología , Persona de Mediana Edad , Tamaño de los Órganos , Adulto JovenRESUMEN
Cannabis, or the dried leaves, stems, and seeds of the hemp plant Cannabis sativa, is the most widely used illicit drug in America. Typically smoked, vaporized or ingested orally, cannabis is used primarily for recreational purposes, though a few synthetic cannabinoids have been approved for medicinal treatments. Psychoactive cannabinoids, or the pharmacologically active compounds within cannabis, are responsible for producing the infamous "high" sensation, characterized by feelings of euphoria and relaxation, though can also provoke hallucinations, paranoia and anxiety. Cannabinoids act on G-protein coupled receptors in the brain, primarilyCB1 receptors, that typically decrease neural activity and modulate transmitter release. Compared to other drugs of abuse, cannabis use has minimal health risks and almost no potential for fatal overdose, though the trademark method of administration (smoking) has detrimental consequences. Chronic heavy use can also lead to changes in memory, cognitive deficits, psychosis and dependence. Up to 9% of users can develop a cannabis dependence, characterized by a characteristic withdrawal syndrome. The growing prevalence of cannabis use has spurred the development of animals models to research the neurobehavioral basis of cannabis use. Traditional animal models of drug abuse (i.e., conditioned place preference (CPP) and self-administration) have historically struggled to establish rewarding or reinforcing effects of individual cannabinoid molecules. Decades of research have been needed to reveal the appropriate dosage and conditions to promote reward and reinforcement in animal models. While the field has made great strides in elucidating the mechanisms involved in behavioral pharmacology cannabinoids, the social aspects of cannabis use remains underrepresented in animal models. Social interactions are vital to the initiation and continuation of cannabis use in humans, and this component has yet to be accurately captured in current animal models.
Asunto(s)
Cannabinoides/farmacología , Modelos Animales de Enfermedad , Endocannabinoides/metabolismo , Abuso de Marihuana , Uso de la Marihuana , Conducta Social , Animales , Conducta Animal , Humanos , Abuso de Marihuana/etiología , Abuso de Marihuana/metabolismo , Abuso de Marihuana/patología , Abuso de Marihuana/fisiopatología , Uso de la Marihuana/metabolismo , Uso de la Marihuana/patología , Uso de la Marihuana/psicologíaRESUMEN
PURPOSE: The aim of this study was at evaluating the effects of long-term cannabis use on the corneal endothelial cells with the specular microscopy. METHODS: The study enrolled 28 eyes of 28 patients diagnosed with cannabinoid use disorder. The cannabinoid group was selected among patients who had been using the substance for three days or more per week over the past one year. Thirty-two eyes of 32 age- and sex-matched healthy individuals enrolled as control group in the study. Corneal endothelial cell density (CD), coefficient of variation (CV) and hexagonal cell ratio (HEX) values were analyzed by specular microscopy. RESULTS: The mean CD was 2900 ± 211 cells/mm2 in the cannabinoid group and 3097 ± 214 cells/mm2 in the control group (p < 0.01). There was a significant decrease in cannabinoid group. The mean CV was 29 ± 7 and 27 ± 4 in the cannabinoid and control groups, respectively (p > 0.05). No significant difference was present between the cannabinoid and the control groups in terms of mean CV value. The mean HEX was 52 ± 5% in the cannabinoid group and 53 ± 10% in the control group (p > 0.05). There was not a significant difference between the cannabinoid and the control groups in terms of mean HEX value. CONCLUSION: A significant decrease in CD was found in cannabinoid users compared the control group.
Asunto(s)
Cannabinoides/toxicidad , Endotelio Corneal/efectos de los fármacos , Abuso de Marihuana/patología , Adulto , Endotelio Corneal/patología , Femenino , Humanos , Masculino , Adulto JovenRESUMEN
Both acute and regular cannabis use affects the functioning of the brain. While several studies have demonstrated that regular cannabis use can impair the capacity to synchronize neural assemblies during specific tasks, less is known about spontaneous brain activity. This can be explored by measuring EEG complexity, which reflects the spontaneous variability of human brain activity. A recent study has shown that acute cannabis use can affect that complexity. Since the characteristics of cannabis use can affect the impact on brain functioning, this study sets out to measure EEG complexity in regular cannabis users with or without dependence, in comparison with healthy controls. We recruited 26 healthy controls, 25 cannabis users without cannabis dependence and 14 cannabis users with cannabis dependence, based on DSM IV TR criteria. The EEG signal was extracted from at least 250 epochs of the 500ms pre-stimulation phase during a visual evoked potential paradigm. Brain complexity was estimated using Lempel-Ziv Complexity (LZC), which was compared across groups by non-parametric Kruskall-Wallis ANOVA. The analysis revealed a significant difference between the groups, with higher LZC in participants with cannabis dependence than in non-dependent cannabis users. There was no specific localization of this effect across electrodes. We showed that cannabis dependence is associated to an increased spontaneous brain complexity in regular users. This result is in line with previous results in acute cannabis users. It may reflect increased randomness of neural activity in cannabis dependence. Future studies should explore whether this effect is permanent or diminishes with cannabis cessation.
Asunto(s)
Ondas Encefálicas/fisiología , Encéfalo/fisiopatología , Abuso de Marihuana/patología , Abuso de Marihuana/fisiopatología , Adolescente , Adulto , Mapeo Encefálico , Electroencefalografía , Femenino , Humanos , Modelos Logísticos , Masculino , Escalas de Valoración Psiquiátrica , Estudios Retrospectivos , Estadísticas no Paramétricas , Adulto JovenRESUMEN
Synthetic marijuana use is an emerging public health problem in the United States, and can cause agitation, severe psychosis, bizarre hallucinations, and possibly death. This article describes these products, which are unregulated and can vary widely in composition, and how clinicians can recognize patients with synthetic cannabinoid toxicity and treat them appropriately to minimize morbidity and mortality.
Asunto(s)
Cannabinoides/toxicidad , Drogas de Diseño/toxicidad , Abuso de Marihuana/patología , Acatisia Inducida por Medicamentos/etiología , Alucinaciones/inducido químicamente , Humanos , Abuso de Marihuana/complicaciones , Abuso de Marihuana/diagnóstico , Psicosis Inducidas por Sustancias/etiología , Estados UnidosRESUMEN
Orbitofrontal cortex (OFC) sulcogyral patterns are stable morphological variations established early in life. They consist of three distinct pattern types, with Type III in particular being associated with poor regulatory control (e.g., high sensation seeking and negative emotionality, low constraint), which may confer risk for earlier onset of cannabis (CB) use and greater use in later life. The OFC sulcogyral pattern may therefore be a stable trait marker in understanding individual differences in substance-use vulnerability and associated affective disturbances in users. In a large multisite cross-sectional study, we compared OFC pattern type distribution between 128 healthy controls (HC) and 146 CB users. Within users (n=140), we explored the association between OFC pattern type and CB use level, and subsequently if level of CB use informed by OFC pattern type may mediate disturbances in affective tone, as indexed by depressive symptoms. While OFC pattern distribution did not distinguish between HC and CB groups, it informed greater lifetime use within users. Specifically, CB users with pattern Type III in the right OFC tended to use more CB over their lifetime, than did CB users with pattern Type I or II. Greater lifetime CB use was subsequently associated with higher depressive symptoms, such that it mediated an indirect association between right OFC pattern Type III and higher depressive symptoms. The present study provides evidence for neurobiological differences, specifically sulcogyral pattern of the OFC, to modulate level of CB use, which may subsequently influence the expression of depressive symptoms.
Asunto(s)
Depresión/diagnóstico por imagen , Abuso de Marihuana/diagnóstico por imagen , Uso de la Marihuana/patología , Corteza Prefrontal/diagnóstico por imagen , Adolescente , Adulto , Estudios Transversales , Depresión/patología , Femenino , Lateralidad Funcional , Humanos , Inteligencia , Imagen por Resonancia Magnética , Masculino , Abuso de Marihuana/patología , Persona de Mediana Edad , Corteza Prefrontal/patología , Adulto JovenRESUMEN
Prospective epidemiological studies have consistently demonstrated that cannabis use is associated with an increased subsequent risk of both psychotic symptoms and schizophrenia-like psychoses. Early onset of use, daily use of high-potency cannabis, and synthetic cannabinoids carry the greatest risk. The risk-increasing effects are not explained by shared genetic predisposition between schizophrenia and cannabis use. Experimental studies in healthy humans show that cannabis and its active ingredient, delta-9-tetrahydrocannabinol (THC), can produce transient, dose-dependent, psychotic symptoms, as well as an array of psychosis-relevant behavioral, cognitive and psychophysiological effects; the psychotogenic effects can be ameliorated by cannabidiol (CBD). Findings from structural imaging studies in cannabis users have been inconsistent but functional MRI studies have linked the psychotomimetic and cognitive effects of THC to activation in brain regions implicated in psychosis. Human PET studies have shown that acute administration of THC weakly releases dopamine in the striatum but that chronic users are characterised by low striatal dopamine. We are beginning to understand how cannabis use impacts on the endocannabinoid system but there is much still to learn about the biological mechanisms underlying how cannabis increases risk of psychosis. This article is part of the Special Issue entitled "A New Dawn in Cannabinoid Neurobiology".
Asunto(s)
Cannabinoides/efectos adversos , Abuso de Marihuana/patología , Abuso de Marihuana/fisiopatología , Neuroimagen , Psicosis Inducidas por Sustancias/patología , Psicosis Inducidas por Sustancias/fisiopatología , Humanos , Abuso de Marihuana/diagnóstico por imagen , Psicosis Inducidas por Sustancias/diagnóstico por imagenRESUMEN
AIMS: Marijuana is a widely used illicit drug and its consumption during pregnancy has been associated with adverse reproductive outcomes. The purpose of this study was to determine the effects of chronic intake of Δ9-tetrahydrocannabinol (THC), the major component of marijuana, on trophoblast function, placental development, and birth outcomes. METHODS: The pathological characteristics and distribution of cannabinoid receptors in placenta were observed by immunohistochemical (IHC) staining. Cell migration in response to THC was measured by transwell assays. The levels of cannabinoid receptors and Signal Transducer and Activator of Transcription 3 (STAT3) were detected by western blot. RESULTS: We found the placenta expressed two main cannabinoid receptors, suggesting that THC induced biological responses in placental cells. Supporting this hypothesis, we observed dramatic alterations of placental morphology in marijuana users. Using THC and inhibitors of cannabinoid receptors, we demonstrated that THC impaired trophoblast cell migration and invasion partly via cannabinoid receptors. Additionally, pregnant mice injected with THC showed adverse reproductive events including reduced number of fetuses, lower maternal and placental weights. Mechanistically, STAT3 signaling pathway was involved in the THC-induced suppression of trophoblast cell motility and pregnancy outcomes. CONCLUSION: Our study indicates that the STAT3 signaling pathway plays a critical role in THC-induced trophoblast dysfunction.
Asunto(s)
Cannabis/efectos adversos , Dronabinol/efectos adversos , Abuso de Marihuana/genética , Factor de Transcripción STAT3/genética , Adulto , Animales , Tasa de Natalidad , Cannabinoides/efectos adversos , Femenino , Humanos , Abuso de Marihuana/patología , Ratones , Placenta/efectos de los fármacos , Placenta/patología , Embarazo , Receptores de Cannabinoides/biosíntesis , Receptores de Cannabinoides/genética , Factor de Transcripción STAT3/biosíntesis , Transducción de Señal/efectos de los fármacos , Trofoblastos/efectos de los fármacos , Trofoblastos/patologíaRESUMEN
BACKGROUND AND AIMS: Chronic alcohol use is associated with lower gray matter volume, and we reported recently that alcohol use showed negative associations with widespread gray matter (GM) volume even among young adults. The current study aimed to test the strength of association between (1) alcohol use and GM volume; (2) alcohol use and white matter (WM) integrity; (3) cannabis use and GM volume; and (4) cannabis use and WM integrity among adults and adolescents. DESIGN AND SETTING: General linear models within large pooled cross-sectional samples of adolescents and adults who had participated in studies collecting substance use and neuroimaging data in the southwestern United States. PARTICIPANTS: The current analysis included adults aged 18-55 years (n = 853) and adolescents aged 14-18 years (n = 439) with a range of alcohol and cannabis use. MEASUREMENTS: The dependent variable was GM volume or WM integrity, with key predictors of alcohol use [Alcohol Use Disorders Identification Test (AUDIT) score] and cannabis use (past 30-day use). FINDINGS: Alcohol use showed large clusters of negative associations (ηp2 = 0.028-0.145, P < 0.001) with GM volume among adults and to a lesser extent (one cluster; ηp2 = 0.070, P < 0.05) among adolescents. Large clusters showed significant associations (ηp2 = 0.050-0.124, P < 0.001) of higher alcohol use with poorer WM integrity, whereas adolescents showed no significant associations between alcohol use and WM. No associations were observed between structural measures and past 30-day cannabis use in adults or adolescents. CONCLUSIONS: Alcohol use severity is associated with widespread lower gray matter volume and white matter integrity in adults, and with lower gray matter volume in adolescents.